Thursday, May 18, 2017

Diabetes Drug Gets FDA Warning

A type 2 diabetes prescription drug appears to increase the risk of leg and foot amputations
Read doctor-produced health and medical information written for you to make informed decisions about your health concerns.
To view this email as a web page, Click Here
May 18, 2017 Facebook Twitter
FEATURED NEWS
Diabetes Drug Gets FDA Warning
A prescription drug appears to increase the risk of leg and foot amputations.
READ MORE
Some Lead Poisoning Tests May Be Faulty
Heart Disease the No. 1 Killer Worldwide
Nuts! Good Medicine for Colon Cancer Survivors?
Drink Water, Fight Fat?
See All News →
FEATURED SLIDESHOW
Signs of Deep Vein Thrombosis
Deep vein thrombosis is a blood clot that forms inside a vein deep within your leg.
VIEW SLIDESHOW
Tips for Living with Atrial Fibrillation
Essential Screening Tests Every Man Needs
Multiple Sclerosis (MS) Symptoms, Treatment
Why We Get Ear Infections
See All Slideshows →
FEATURED QUIZ
How Common Is Heart Disease?
Learn facts about congenital heart disease, symptoms, signs, and prevention.
TAKE THE QUIZ
What Is Crohn's Disease?
Eye Problems & Conditions Quiz
Are You Experiencing Menopause?
Signs of Psoriasis
See All Quizzes →
Health & Wellness Guide
BONUS
Health & Wellness Guide
Claim Your FREE PDF MedicineNet Health Report!
ADVERTISEMENT
HEALTH TOOLS
MEDICINENET NEWSLETTERS
Sign up for the NEW MedicineNet newsletters today! New specialty newsletters include Cancer, Heart, Pregnancy & Newborns, Children's Health & Parenting.
SIGN UP
FROM OUR WEBMD SPONSORS  arrow
You received this message because you signed up for the Daily Health News newsletter as brandee-garner-0662.7888@blogger.com.

Don't miss a single issue of this newsletter. Add MedicineNet.com to your email's safe sender list.

Need to add, change, or remove your subscriptions?
Manage your MedicineNet newsletter preferences here.

MedicineNet respects your privacy - view our Privacy Policy

MedicineNet
903 Calle Amanecer, Suite 300 San Clemente, CA 92673 USA
© MedicineNet, Inc. All rights reserved.

No comments:

Post a Comment